Leptin resistance may be responsible for elevated leptin levels in obese women with polycystic ovary syndrome, according to authors of this study.
Polycystic Ovary Syndrome (PCOS)
The GLP-1 receptor agonist/metformin combination did not support weight loss in this population but did increase pregnancy rates per in vitro embryo transfer.
Our December list includes pharmaceutical company responses to soaring insulin costs, delayed PCOS diagnosis, and dementia risk with ADT.
Our November list includes an injectable male contraceptive, resveratrol treatment for PCOS, and novel gene associated with Addison disease.
Women with polycystic ovary syndrome (PCOS) are at increased risk for metabolic and heart diseases and nearly twice as likely to be hospitalized.
In an adolescent, polycystic ovary syndrome should be diagnosed cautiously. The typical symptoms of PCOS in an adult may just be developmental irregularities in a teen.
The Role of Practical Lifestyle Changes
PCOS is a metabolic disorder that affects 5 – 7.5% of all women. It is the number one cause of infertility and if left untreated, can increase risk of endometrial cancer. In addition, women with PCOS are at a greater risk for heart disease and diabetes.
Polycystic ovary syndrome is characterized by anovulation (irregular or absent menstrual periods) and hyperandrogenism (elevated serum testosterone and androstenedione). Patients with this syndrome may complain of abnormal bleeding, infertility, obesity, excess hair growth, hair loss and acne.
Polycystic ovaries (PCO) and their clinical expression (the polycystic ovary syndrome [PCOS]) as well as type 2 diabetes mellitus (T2DM) are common medical conditions linked through insulin resistance. We studied the prevalence of PCO and PCOS in women with diet and/or oral hypoglycemic treated T2DM and non-diabetic control women.